The MedDRA Management Committee (MC) has responsibility for direction of MedDRA, an ICH standardised dictionary of medical terminology. The MedDRA MC is composed of the EC, Europe / EFPIA / MHLW/PMDA, Japan / JPMA / FDA, US / PhRMA, the Medicines and Healthcare products Regulatory Agency (MHRA) of the UK, Health Canada, Canada and WHO (as Observer). 

 

 

 
Filter:

EC, Europe

Mr. Georgios Balkamos

Policy Officer

Dr. Sabine Brosch

Principal Scientific Administrator

EFPIA

Dr. Christina Winter

Medical Director

Mrs. Claudia Lehmann

Vice President, Head Global PV Operations

FDA, US

Ms. MaryAnn Slack

Deputy Director
Office of Planning and Informatics

Dr. Christopher Jankosky

Associate Director for Medical Policy

Health Canada, Canada

Ms. Sophie Sommerer

Director

Ms. Heather Morrison

Adverse Reaction Information and Issues Management Coordinator

JPMA

Mr. Yo Tanaka

Senior Specialist

Ms. Yoko Hattori

Manager

MHLW/PMDA, Japan

Dr. Kiyomi Ueno

Director 

Ms. Yuka Tamura

Reviewer

MHRA UK

Mr. Mick Foy

Group Manager

PhRMA

Dr. Peter K. Honig

Senior Vice President

Ms. Camille Jackson

Senior Director

WHO

Mr. Mike Ward

Coordinator

Dr. Daisuke Tanaka

Technical Officer